SpecificationsOrganism/cell line/tissue*Mus musculus*/cerebral cortex, cerebellum and hippocampusStrain(s)Ts1Cje (on a C56BL/6 background) & disomic littermates (assumed to be C56BL/6)SexFemaleSequencer or array typeAffymetrix Gene-Chip® Mouse Genome 430 2.0 arraysData formatNormalised dataExperimental factorsTs1Cje vs disomic littermates; age (P1, P15, P30 and P84); brain regions (cerebral cortex, cerebellum and hippocampus)Experimental features72 microarray datasets encompass Ts1Cje vs disomic littermates, four postnatal time-points and three brain regionsConsentn/aSample source locationn/a

Direct link to deposited data {#s0010}
=============================

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49050>.

Experimental design, materials and methods {#s0015}
==========================================

Experimental approach {#s0020}
---------------------

Three main brain regions including the cerebral cortex, cerebellum and hippocampus were targeted in the study. Transcriptomes of these brain regions from 3 Ts1Cje and 3 disomic littermate control were compared at each of the following time-points: P1, P15, P30 and P84. The tissue samples were randomised prior to RNA extraction, quantitation of total RNA and quality/integrity, cRNA preparation and microarray hybridisation steps ([Table 1](#t0005){ref-type="table"}). [Fig. 1](#f0005){ref-type="fig"}(A) is a simplified diagram of the experimental design and data processing flow/criteria used for the study.

Ts1Cje mouse breeding, ethics statement and genotyping {#s0025}
------------------------------------------------------

Ts1Cje and disomic mice were generated by mating Ts1Cje males (originally obtained from The Jackson Laboratory, Bar Harbour, USA) with C57BL/6 female mice for over 10 generations. All mice were kept in a controlled environment of 12-h light/12-h dark cycle with unlimited access to a standard pellet diet and water. Breeding procedures, husbandry and all experiments were performed under the approval from the Walter and Eliza Hall Institute Animal Ethics Committee (Project numbers 2001.45, 2004.041 and 2007.007). Genomic DNA was extracted from mouse-tails and genotyping was performed using multiplex PCR with primers for neomycin (*neo*) and the glutamate receptor, ionotropic, kainite 1 (*Grik1*) as an internal control as described previously [@bb0020].

Tissue procurement {#s0030}
------------------

Three female Ts1Cje mice at four time-points (P1, P15, P30 and P84) with sex and age matched disomic littermates were used to avoid the effects of Y-linked genes such as *Sry* (sex-determining region of the Y chromosome), which contribute to neural sexual differentiation of the brain [@bb0025]. All mice were euthanized via cervical dislocation. Procurement of the cerebral cortex, cerebellum and hippocampus was conducted according to a method described previously [@bb0030].

RNA extraction and microarray hybridisation {#s0035}
-------------------------------------------

The Qiagen RNeasy Micro kit (Qiagen) with a DNase I digestion step was used to extract total RNA from each tissue according to the manufacturer\'s instructions. All 72 tissues were randomised prior to RNA extraction to avoid biases ([Table 1](#t0005){ref-type="table"}). The quality and quantity of each RNA sample were assessed using an Agilent 2100 Bioanalyzer (Agilent). The RNA Integrity Number (RIN) ranged from 7.0 to 10. Six micrograms of total RNA was used to prepare biotinylated cRNA according to the standard Affymetrix protocol (Expression Analysis Technical Manual, 2001, Affymetrix). Hybridisation of labelled RNA samples onto Affymetrix GeneChip Mouse Genome 430 2.0 Arrays was performed according to the Australian Genome Research Facility (AGRF) protocol. A probe cocktail (cRNA at 0.05 μg/μl), which included 1× Hybridisation Buffer (100 mM MES, 1 M NaCl, 20 mM EDTA, 0.01% Tween-20), 0.1 mg/ml Herring Sperm DNA, 0.5 mg/ml BSA, and 7% DMSO was prepared to a total of 300 μl for each sample and 200 μl was hybridised onto a single GeneChip. The chips were incubated at 45 °C for 16 h in an oven with a rotating wheel at 60 rpm, washed and stained with streptavidin-phycoerythrin (SAPE) using the appropriate fluidics script on the Affymetrix Fluidics Station 450 (Affymetrix). The GeneChips were scanned using a GeneChip Scanner 3000® (Affymetrix) with GeneChip® Operating Software (GCOS). [Fig. 1](#f0005){ref-type="fig"}(B) shows a simplified diagram of the sample preparation.

Microarray data normalisation and analysis {#s0040}
------------------------------------------

The microarray data was analysed using R ([www.r-project.org](http://www.r-project.org){#ir0765}) and Bioconductor ([www.bioconductor.org](http://www.bioconductor.org){#ir0770}) [@bb0035]. The probe-level intensities for the 72 arrays were background corrected, normalised and summarised using the GC Robust Multi-array Average (GC-RMA) algorithm [@bb0040] to obtain gene (probe-set) level summaries (see Supplementary File 1 for GC-RMA script used). Differential expression between Ts1Cje and their disomic littermates at different time-points and in different brain regions was assessed using the limma package [@bb0045]. A linear model was fitted for multiple contrasts (corresponding to the Ts1Cje vs disomic comparisons) for each gene using the lmFit procedure and differential expression was assessed using empirical Bayes moderated *t*-statistics [@bb0050]. P-values corresponding to the moderated *t*-statistics were adjusted for multiple testing using the false discovery rate (FDR) procedure of Benjamini and Hochberg [@bb0055]. [Fig. 1](#f0005){ref-type="fig"}(C) shows a simplified diagram of the microarray analysis.

Stringent criteria were applied to identify differentially expressed genes (DEGs) from the datasets, which included *t-*statistic values of ≥ 4 or ≤ -4 and a FDR of ≤ 0.05. As reported in Ling et al. [@bb0060], a total number of 317 DEGs were identified from all spatiotemporal comparisons. A top-down screening approach was then used to analyse the 317 DEGs in order to identify any disrupted molecular pathways. Initially, a functional ontology clustering analysis based on all 317 DEGs collectively using the Database for Annotation, Visualisation and Integrated Discovery (DAVID) [@bb0065] was performed. The functional clustering analysis was performed under a stringent classification criteria (a kappa similarity threshold of 0.85, a minimum term overlap of three, two initial and final group membership with a 0.50 multiple linkage threshold and a modified Fisher-exact P-value or enrichment thresholds of 0.05) using the following databases: Biological Biochemical Image Database (BBID), BioCarta database, EC_number, Kyoto Encyclopedia of Genes and Genomes (KEGG) database, PANTHER pathway database and Reactome pathway database [@bb0065]. Subsequently, a more refined analysis was carried out involving the DEGs identified from the comparisons that were based on a specific time-point or brain region. Finally, the significant ontologies identified through all analyses were manually curated based on common genes that were found involved in the ontologies leading to the identification of 7 significant functional clusters. [Fig. 1](#f0005){ref-type="fig"}(D) shows a simplified diagram of the functional clustering analysis.

Discussion {#s0005}
==========

Here we provide a detailed description of the generation of a 72 microarray dataset, which is comprised of transcriptome profiling data derived from three brain regions, at four postnatal time-points from the Ts1Cje mouse model of DS and disomic littermates. The strategy used to identify DEGs between the Ts1Cje and disomic littermate data and functional clustering analysis is also described. This comprehensive and well-controlled microarray dataset encompasses postnatal developmental stages from P1 to P84 in the cerebral cortex, cerebellum and hippocampus providing a platform to understand the differences between the Ts1Cje and disomic mouse brain in these regions at a transcriptome level. The analysis of the dataset was fully described and discussed in the study by Ling et al. [@bb0060], which demonstrated that the interferon-related pathways were significantly dysregulated in the Ts1Cje brain as compared to their disomic littermates.

Appendix A. Supplementary data {#s0045}
==============================

Supplementary material: GC Robust Multi-array Average (GC-RMA) script used to determine the probe-level intensities for the 72 arrays.

This work was supported by the National Health and Medical Research Council fellowships (461204 and APP1023059 to HSS); National Health and Medical Research Council Grants 219176, 257501, and 215201 (to HSS and GKS); Sciencefund Grant, MOSTI, Malaysia (02-01-04-SF1306) awarded to P-SC; Research University Grant Scheme, Universiti Putra Malaysia (04-02-12-2102RU) awarded to K-HL; and the APEX Foundation for Research into Intellectual Disability Limited to CAH. K-LT was a recipient of the Malaysian Ministry of Higher Education MyPhD scholarship. The microarrays were performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities programme.

Supplementary data to this article can be found online at [http://dx.doi.org/10.1016/j.gdata.2014.09.009](10.1016/j.gdata.2014.09.009){#ir0775}.

![Outline of experimental design (A), sample preparation (B), microarray data analysis (C), and functional clustering analysis using DAVID tools (D). Ts1Cje denotes Down syndrome mice, cRNA denotes complementary RNA, GCRMA denotes Guanine Cytosine Robust Multi-Array Analysis, FDR denotes false discovery rate, DAVID denotes Database for Annotation, Visualization and Integrated Discovery.](gr1){#f0005}

###### 

Sample randomisation prior to RNA extraction, determination of total RNA sample quality/integrity, cRNA preparation and microarray hybridization steps.

  Day   Week   Tube   Mouse ID    Strain    Age   Tissue            Accession ID
  ----- ------ ------ ----------- --------- ----- ----------------- --------------------------------------------
  1     1      1      10.1.1      Disomic   P1    Hippocampus       [GSM1193014](ncbi-geo:GSM1193014){#ir0390}
  1     1      2      A40         Ts1Cje    P84   Cerebral cortex   [GSM1193015](ncbi-geo:GSM1193015){#ir0395}
  1     1      3      A104        Ts1Cje    P30   Cerebral cortex   [GSM1193016](ncbi-geo:GSM1193016){#ir0400}
  1     1      4      10.1.3      Ts1Cje    P1    Cerebellum        [GSM1193017](ncbi-geo:GSM1193017){#ir0405}
  1     1      5      A104        Ts1Cje    P30   Hippocampus       [GSM1193018](ncbi-geo:GSM1193018){#ir0410}
  1     1      6      A63         Disomic   P15   Cerebral cortex   [GSM1193019](ncbi-geo:GSM1193019){#ir0415}
  2     1      7      A40         Ts1Cje    P84   Cerebellum        [GSM1193020](ncbi-geo:GSM1193020){#ir0420}
  2     1      8      10.1.1      Disomic   P1    Cerebellum        [GSM1193021](ncbi-geo:GSM1193021){#ir0425}
  2     1      9      A41         Disomic   P84   Hippocampus       [GSM1193022](ncbi-geo:GSM1193022){#ir0430}
  2     1      10     A60         Ts1Cje    P15   Cerebral cortex   [GSM1193023](ncbi-geo:GSM1193023){#ir0435}
  2     1      11     A40         Ts1Cje    P84   Hippocampus       [GSM1193024](ncbi-geo:GSM1193024){#ir0440}
  2     1      12     10.1.3      Ts1Cje    P1    Hippocampus       [GSM1193025](ncbi-geo:GSM1193025){#ir0445}
  3     1      13     A103        Disomic   P30   Hippocampus       [GSM1193026](ncbi-geo:GSM1193026){#ir0450}
  3     1      14     A41         Disomic   P84   Cerebellum        [GSM1193027](ncbi-geo:GSM1193027){#ir0455}
  3     1      15     A63         Disomic   P15   Hippocampus       [GSM1193028](ncbi-geo:GSM1193028){#ir0460}
  3     1      16     A41         Disomic   P84   Cerebral cortex   [GSM1193029](ncbi-geo:GSM1193029){#ir0465}
  3     1      17     A60         Ts1Cje    P15   Hippocampus       [GSM1193030](ncbi-geo:GSM1193030){#ir0470}
  3     1      18     A104        Ts1Cje    P30   Cerebellum        [GSM1193031](ncbi-geo:GSM1193031){#ir0475}
  4     1      19     A103        Disomic   P30   Cerebellum        [GSM1193032](ncbi-geo:GSM1193032){#ir0480}
  4     1      20     10.1.3      Ts1Cje    P1    Cerebral cortex   [GSM1193033](ncbi-geo:GSM1193033){#ir0485}
  4     1      21     A60         Ts1Cje    P15   Cerebellum        [GSM1193034](ncbi-geo:GSM1193034){#ir0490}
  4     1      22     A103        Disomic   P30   Cerebral cortex   [GSM1193035](ncbi-geo:GSM1193035){#ir0495}
  4     1      23     A63         Disomic   P15   Cerebellum        [GSM1193036](ncbi-geo:GSM1193036){#ir0500}
  4     1      24     10.1.1      Disomic   P1    Cerebral cortex   [GSM1193037](ncbi-geo:GSM1193037){#ir0505}
  5     2      25     A44         Ts1Cje    P84   Hippocampus       [GSM1193038](ncbi-geo:GSM1193038){#ir0510}
  5     2      26     10.1.5      Ts1Cje    P1    Cerebellum        [GSM1193039](ncbi-geo:GSM1193039){#ir0515}
  5     2      27     A91         Disomic   P15   Hippocampus       [GSM1193041](ncbi-geo:GSM1193041){#ir0520}
  5     2      28     105         Disomic   P30   Cerebral cortex   [GSM1193044](ncbi-geo:GSM1193044){#ir0525}
  5     2      29     105         Disomic   P30   Hippocampus       [GSM1193048](ncbi-geo:GSM1193048){#ir0530}
  5     2      30     10.1.5      Ts1Cje    P1    Hippocampus       [GSM1193049](ncbi-geo:GSM1193049){#ir0535}
  6     2      31     A91         Disomic   P15   Cerebellum        [GSM1193050](ncbi-geo:GSM1193050){#ir0540}
  6     2      32     A33 3.2.4   Ts1Cje    P30   Cerebellum        [GSM1193051](ncbi-geo:GSM1193051){#ir0545}
  6     2      33     10.1.2      Disomic   P1    Cerebral cortex   [GSM1193052](ncbi-geo:GSM1193052){#ir0550}
  6     2      34     10.1.5      Ts1Cje    P1    Cerebral cortex   [GSM1193053](ncbi-geo:GSM1193053){#ir0555}
  6     2      35     10.1.2      Disomic   P1    Cerebellum        [GSM1193054](ncbi-geo:GSM1193054){#ir0560}
  6     2      36     A92         Ts1Cje    P15   Cerebral cortex   [GSM1193055](ncbi-geo:GSM1193055){#ir0565}
  7     2      37     10.1.2      Disomic   P1    Hippocampus       [GSM1193056](ncbi-geo:GSM1193056){#ir0570}
  7     2      38     A33 3.2.4   Ts1Cje    P30   Hippocampus       [GSM1193057](ncbi-geo:GSM1193057){#ir0575}
  7     2      39     A42/43      Disomic   P84   Cerebellum        [GSM1193058](ncbi-geo:GSM1193058){#ir0580}
  7     2      40     A91         Disomic   P15   Cerebral cortex   [GSM1193059](ncbi-geo:GSM1193059){#ir0585}
  7     2      41     A42/43      Disomic   P84   Cerebral cortex   [GSM1193060](ncbi-geo:GSM1193060){#ir0590}
  7     2      42     A92         Ts1Cje    P15   Cerebellum        [GSM1193061](ncbi-geo:GSM1193061){#ir0595}
  8     2      43     105         Disomic   P30   Cerebellum        [GSM1193062](ncbi-geo:GSM1193062){#ir0600}
  8     2      44     A42/43      Disomic   P84   Hippocampus       [GSM1193063](ncbi-geo:GSM1193063){#ir0605}
  8     2      45     A92         Ts1Cje    P15   Hippocampus       [GSM1193064](ncbi-geo:GSM1193064){#ir0610}
  8     2      46     A44         Ts1Cje    P84   Cerebral cortex   [GSM1193065](ncbi-geo:GSM1193065){#ir0615}
  8     2      47     A33 3.2.4   Ts1Cje    P30   Cerebral cortex   [GSM1193066](ncbi-geo:GSM1193066){#ir0620}
  8     2      48     A44         Ts1Cje    P84   Cerebellum        [GSM1193067](ncbi-geo:GSM1193067){#ir0625}
  9     3      49     A76         Ts1Cje    P15   Cerebellum        [GSM1193068](ncbi-geo:GSM1193068){#ir0630}
  9     3      50     A34 3.2.5   Ts1Cje    P30   Hippocampus       [GSM1193069](ncbi-geo:GSM1193069){#ir0635}
  9     3      51     10.1.9      Ts1Cje    P1    Cerebellum        [GSM1193070](ncbi-geo:GSM1193070){#ir0640}
  9     3      52     106         Disomic   P30   Cerebellum        [GSM1193071](ncbi-geo:GSM1193071){#ir0645}
  9     3      53     A49         Ts1Cje    P84   Hippocampus       [GSM1193072](ncbi-geo:GSM1193072){#ir0650}
  9     3      54     A76         Ts1Cje    P15   Hippocampus       [GSM1193073](ncbi-geo:GSM1193073){#ir0655}
  10    3      55     A76         Ts1Cje    P15   Cerebral cortex   [GSM1193074](ncbi-geo:GSM1193074){#ir0660}
  10    3      56     10.1.7      Disomic   P1    Hippocampus       [GSM1193075](ncbi-geo:GSM1193075){#ir0665}
  10    3      57     106         Disomic   P30   Cerebral cortex   [GSM1193076](ncbi-geo:GSM1193076){#ir0670}
  10    3      58     A49         Ts1Cje    P84   Cerebellum        [GSM1193077](ncbi-geo:GSM1193077){#ir0675}
  10    3      59     A50         Disomic   P84   Hippocampus       [GSM1193078](ncbi-geo:GSM1193078){#ir0680}
  10    3      60     A49         Ts1Cje    P84   Cerebral cortex   [GSM1193079](ncbi-geo:GSM1193079){#ir0685}
  11    3      61     A50         Disomic   P84   Cerebellum        [GSM1193080](ncbi-geo:GSM1193080){#ir0690}
  11    3      62     10.1.9      Ts1Cje    P1    Cerebral cortex   [GSM1193081](ncbi-geo:GSM1193081){#ir0695}
  11    3      63     A34 3.2.5   Ts1Cje    P30   Cerebral cortex   [GSM1193082](ncbi-geo:GSM1193082){#ir0700}
  11    3      64     10.1.7      Disomic   P1    Cerebral cortex   [GSM1193083](ncbi-geo:GSM1193083){#ir0705}
  11    3      65     A34 3.2.5   Ts1Cje    P30   Cerebellum        [GSM1193084](ncbi-geo:GSM1193084){#ir0710}
  11    3      66     A75         Disomic   P15   Cerebral cortex   [GSM1193085](ncbi-geo:GSM1193085){#ir0715}
  12    3      67     A75         Disomic   P15   Hippocampus       [GSM1193086](ncbi-geo:GSM1193086){#ir0720}
  12    3      68     10.1.7      Disomic   P1    Cerebellum        [GSM1193087](ncbi-geo:GSM1193087){#ir0725}
  12    3      69     A75         Disomic   P15   Cerebellum        [GSM1193088](ncbi-geo:GSM1193088){#ir0730}
  12    3      70     10.1.9      Ts1Cje    P1    Hippocampus       [GSM1193089](ncbi-geo:GSM1193089){#ir0735}
  12    3      71     106         Disomic   P30   Hippocampus       [GSM11930](ncbi-geo:GSM11930){#ir0740}90
  12    3      72     A50         Disomic   P84   Cerebral cortex   [GSM1193091](ncbi-geo:GSM1193091){#ir0745}

Note: 'Day' and 'Week' refer to the different days in different weeks on which RNA was extracted from these samples. All samples were  relabelled with a set of continuous numbers under the 'Tube' column. 'Mouse ID' refers to the internal identification number used in the animal facilities where these mice were bred and maintained. 'Accession ID' refers to GEO sample ID deposited under the [GSE49050](ncbi-geo:GSE49050){#ir0750} data series. Within the 'Strain' column, Ts1Cje denotes mouse model of Down syndrome mice. Under the 'Age' column, P denotes 'Postnatal Development Day'.

[^1]: Equal contributors.
